-+ 0.00%
-+ 0.00%
-+ 0.00%

CytoSorbents CEO Phillip P. Chan buys 200,000 common shares for USD 70,000

PUBT·09/09/2026 20:06:11
Listen to the news
CytoSorbents CEO Phillip P. Chan buys 200,000 common shares for USD 70,000
  • CytoSorbents CEO Phillip P. Chan bought 200,000 common shares in the open market at a weighted-average price of $0.35.
  • His beneficial ownership rose to 1,944,432 shares following the purchase.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CytoSorbents Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-106308), on September 09, 2026, and is solely responsible for the information contained therein.